Exact Sciences Corp (EXAS)
62.10
+1.56
(+2.58%)
USD |
NASDAQ |
May 03, 16:00
62.10
0.00 (0.00%)
After-Hours: 20:00
Exact Sciences Cash from Financing (TTM): 159.77M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 159.77M |
| September 30, 2023 | 159.83M |
| June 30, 2023 | 159.98M |
| March 31, 2023 | 207.35M |
| December 31, 2022 | 76.48M |
| September 30, 2022 | 54.19M |
| June 30, 2022 | 54.03M |
| March 31, 2022 | 3.962M |
| December 31, 2021 | 8.472M |
| September 30, 2021 | 900.53M |
| June 30, 2021 | 904.60M |
| March 31, 2021 | 907.39M |
| December 31, 2020 | 1.880B |
| September 30, 2020 | 1.006B |
| June 30, 2020 | 1.003B |
| March 31, 2020 | 992.54M |
| December 31, 2019 | 253.18M |
| September 30, 2019 | 255.91M |
| June 30, 2019 | 274.00M |
| March 31, 2019 | 501.83M |
| December 31, 2018 | 934.14M |
| September 30, 2018 | 927.51M |
| June 30, 2018 | 910.89M |
| March 31, 2018 | 933.39M |
| December 31, 2017 | 260.96M |
| Date | Value |
|---|---|
| September 30, 2017 | 261.60M |
| June 30, 2017 | 403.85M |
| March 31, 2017 | 149.34M |
| December 31, 2016 | 149.59M |
| September 30, 2016 | 148.73M |
| June 30, 2016 | 178.19M |
| March 31, 2016 | 181.72M |
| December 31, 2015 | 181.76M |
| September 30, 2015 | 285.12M |
| June 30, 2015 | 111.09M |
| March 31, 2015 | 244.32M |
| December 31, 2014 | 244.03M |
| September 30, 2014 | 138.40M |
| June 30, 2014 | 138.90M |
| March 31, 2014 | 74.75M |
| December 31, 2013 | 74.76M |
| September 30, 2013 | 75.08M |
| June 30, 2013 | 132.42M |
| March 31, 2013 | 58.77M |
| December 31, 2012 | 60.40M |
| September 30, 2012 | 87.19M |
| June 30, 2012 | 29.54M |
| March 31, 2012 | 29.53M |
| December 31, 2011 | 27.90M |
| September 30, 2011 | 65.46M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
3.962M
Minimum
Mar 2022
1.880B
Maximum
Dec 2020
487.44M
Average
253.18M
Median
Dec 2019
Cash from Financing (TTM) Benchmarks
| Illumina Inc | -1.21B |
| Guardant Health Inc | 477.38M |
| Natera Inc | 254.46M |
| Quest Diagnostics Inc | 83.00M |
| Castle Biosciences Inc | -2.298M |